Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENLIUS

33.950
+1.9506.09%
Volume:2.44M
Turnover:82.64M
Market Cap:18.45B
PE:21.15
High:35.450
Open:32.150
Low:32.000
Close:32.000
Loading ...

BRIEF-Fosun Pharmaceutical To Buy Back Shares

Reuters
·
22 Jan

Shanghai Fosun Pharmaceutical Says Unit's Plan to Merge With Henlius Biotech Failed to Pass Henlius's Shareholder Meeting

THOMSON REUTERS
·
22 Jan

Rpt-Shanghai Fosun Pharma - Merger Was Not Approved at H Shareholders' Class Meeting.

THOMSON REUTERS
·
22 Jan

BRIEF-Shanghai Fosun Pharma Says Privatisation Of Shanghai Henlius Biotech Will Not Proceed

Reuters
·
22 Jan

Corrected-Shanghai Fosun Pharma - Proposed Privatisation of Shanghai Henlius Biotech (Not Co) Will Not Proceed and Listing of H Shares on Main Board of Stock Exchange Will Be Maintained

THOMSON REUTERS
·
22 Jan

Henlius Get China Nod for Tumor Drug Clinical Trial

MT Newswires Live
·
13 Jan

BRIEF-Shanghai Henlius Biotech Says Application For Phase 1B/2 Clinical Trial Of Hlx43- For Injection In- Combination With Hansizhuang Approved By NMPA

Reuters
·
10 Jan

Shanghai Henlius Biotech Inc - Application for Phase 1B/2 Clinical Trial of Hlx43- for Injection in- Combination With Hansizhuang Approved by Nmpa

THOMSON REUTERS
·
10 Jan

Essex Bio-Technology Unit's Co-Developed Drug Completes LPLV for Phase 3 Clinical Study

MT Newswires Live
·
06 Jan

Henlius Doses First Patient in Breast Cancer Drug Trial in China

MT Newswires Live
·
24 Dec 2024

Shanghai Fosun Pharmaceutical Subsidiary Signs Cooperation, License Deal

MT Newswires Live
·
20 Dec 2024

BRIEF-Shanghai Henlius Biotech Says Collaboration And License Agreement With Palleon

Reuters
·
19 Dec 2024

Shanghai Henlius Biotech - Collaboration and License Agreement With Palleon for- E-602 and Combination Therapy

THOMSON REUTERS
·
19 Dec 2024

Fosun Pharmaceutical Says Subsidiary Henlius Signs Collaboration and Licensing Agreement With Palleon

THOMSON REUTERS
·
19 Dec 2024

BRIEF-Fosun Pharmaceutical's Subsidiary Signs Agreement With Palleon

Reuters
·
19 Dec 2024

High Growth Tech Stocks Including Shanghai Henlius Biotech

Simply Wall St.
·
19 Dec 2024

BRIEF-UBS Group's Short Position In Shanghai Henlius Biotech Reduced To 0% On Dec 2 From 2.07% - HKEX

Reuters
·
05 Dec 2024

UBS Group's Short Position in Shanghai Henlius Biotech Reduced to 0% on Dec 2 From 2.07% - HKEX

THOMSON REUTERS
·
05 Dec 2024

BRIEF-Shanghai Henlius Biotech Updates On NDA For New Indication Of Hansizhuang

Reuters
·
04 Dec 2024

Henlius Gets Chinese Regulator's Go-Ahead for Phase 2 Clinical Trial of Tumor Drug

MT Newswires Live
·
04 Dec 2024